Bringing the fundamentals into focus…
Back to Denali Therapeutics Inc.
How Denali Therapeutics Inc. stacks up
DNLI · against 299 other Healthcare companies of similar size
Growth
12/ 100
Near the bottom of its peers.
Ranked #270 of 300 · scores higher than 9% of peers
Bars: peers in each 10-point band of the growth score20 peers with a growth score of 10–19, including DNLI · Click a bar to see the companies
Why growth scores 12?
Weighted metrics compared with all Healthcare companies.Mainly because of its 3-year revenue growth, which is weaker than most Healthcare peers.
- slower revenue growth over three years: weaker than 100% of peers. 3-year revenue growth: -78.1% vs peer median 5.8%
- Revenue growth is not reported, so it is left out of the score.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = DNLI, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | DNLI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 300 reported | Not reported | 7.9% | — | — | 33% |
| Earnings per share growthHigher is better · 176 reported | Not reported | 10.5% | — | — | 33% |
| 3-year revenue growthHigher is better · 292 reported | -78.1% | 8.3% | 0% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around DNLI| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 270 | 13.9B CNY (≈$1.9B) | 12 | 29 | |
| 270 | 17.8B CNY (≈$2.5B) | 12 | 39 | |
| 270 | 24.7B CNY (≈$3.5B) | 12 | 39 | |
| 270 | 14.2B CNY (≈$2.0B) | 12 | 10 | |
| 270 | 3.1B USD | 12 | 27 | |
| 275 | 29.2B CNY (≈$4.1B) | 11 | 42 | |
| 276 | 15.0B CNY (≈$2.1B) | 10 | 55 | |
| 277 | 26.5B CNY (≈$3.7B) | 9 | 69 | |
| 277 | 3.7B USD | 9 | 24 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score